Following a negative FDA advisory committee vote earlier this year, the other shoe has dropped for Lundbeck and Otsuka ...

With a Sept. 29 deadline looming for pharmaceutical companies to adhere to President Donald Trump’s most favored nation drug ...

With a fresh endorsement from the FDA, Johnson & Johnson has rounded out Tremfya’s presence in inflammatory bowel disease ...

As Halloween approaches, Exact Sciences is warding off a particularly terrifying occurrence: skipping colorectal cancer ...

AI is now the first place people go to for answers,” according to Jesse Wolfersberger, global lead of I/O Health at Weber ...

While the test was conducted in NSCLC, the FDA approval includes existing solid tumor indications for Keytruda. Merck is ...

Bristol Myers Squibb is exiting the first U.S.-China pharmaceutical joint venture. Kalexo Bio and Ollin Biosciences have ...

Kennedy Jr.’s purge of the committee—seemed to contradict themselves when it came time to vote on a vaccine recommendation.

Stealth’s injection, known as elamipretide, will be sold as Forzinity for the treatment of Barth syndrome, an X-linked ...

Separately, the ACIP members reversed their vote on a recommendation they’d shot down Thursday pertaining to coverage of ...

Eli Lilly has been censured by the U.K. marketing watchdog after a complainant reported being hit by a “bombardment of spam.” ...

Over the last six years, three GLP-1 drugs have been approved for children aged 10 and older with Type 2 diabetes. | Over the ...